Found: 8
Select item for more details and to access through your institution.
Combining Super Learner with high‐dimensional propensity score to improve confounding adjustment: A real‐world application in chronic lymphocytic leukemia.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2024, v. 33, n. 1, p. 1, doi. 10.1002/pds.5678
- By:
- Publication type:
- Article
Racial disparities in chronic lymphocytic leukemia/small lymphocytic lymphoma accounting for small molecule inhibitors: A real‐world cohort analysis.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 4, p. 780, doi. 10.1002/ajh.27241
- By:
- Publication type:
- Article
Bleeding with concomitant ibrutinib and oral anticoagulant therapy: A population‐based cohort study.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 3, p. E49, doi. 10.1002/ajh.26802
- By:
- Publication type:
- Article
Rate of major bleeding with ibrutinib versus bendamustine‐rituximab in chronic lymphocytic leukemia: A population‐based cohort study.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 9, p. E332, doi. 10.1002/ajh.26632
- By:
- Publication type:
- Article
Ibrutinib-associated Arthralgias/Myalgias in Patients With Chronic Lymphocytic Leukemia: Incidence and Impact on Clinical Outcomes.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Zanubrutinib (BGB-3111), a Second-Generation Selective Covalent Inhibitor of Bruton's Tyrosine Kinase and Its Utility in Treating Chronic Lymphocytic Leukemia.
- Published in:
- Drug Design, Development & Therapy, 2021, v. 15, p. 919, doi. 10.2147/DDDT.S250823
- By:
- Publication type:
- Article
How Have Targeted Agents Changed the Treatment Landscape for Elderly Patients with CLL?
- Published in:
- Current Oncology Reports, 2022, v. 24, n. 12, p. 1705, doi. 10.1007/s11912-022-01322-z
- By:
- Publication type:
- Article
Results from a Real-World Multicenter Analysis of 482 Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib: A Look at Racial Differences.
- Published in:
- Targeted Oncology, 2023, v. 18, n. 5, p. 727, doi. 10.1007/s11523-023-00988-0
- By:
- Publication type:
- Article